New Enterprise Associates

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with offices in the United States, India and China. It makes investments across technology and healthcare startups at multiple stages, from seed to growth, including software, cloud, data, internet services, fintech, AI, e-commerce, and enterprise technology, as well as healthcare information technology, life sciences, medical devices, and biopharma. It also considers energy technology and infrastructure opportunities, such as solar, batteries and smart grids. The firm pursues a global approach, with activity in the United States, Asia and other regions, and supports companies through rounds of financing ranging from small to sizable investments as they scale. NEA focuses on building portfolios in software, IT services, consumer technology, and healthcare technology, backing ambitious entrepreneurs across sectors and geographies.

Michael Albert

Associate

Kate Barrett

Partner, Communications

Ali Behbahani

General Partner

Ann Bordetsky

Partner

James Buxton MD

Principal

Past deals in Europe

FIRE1

Venture Round in 2025
FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

Inventiva Pharma

Post in 2024
Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

Inkitt

Series C in 2024
Inkitt operates an online community for writers and readers, offering a platform where authors can share and refine their work while gaining insights from readers. The company uses data-driven approaches to identify popular stories and publishes them across various media, aiming to create blockbuster franchises similar to Disney's model.

Tagworks Pharmaceuticals

Series A in 2023
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.

FIRE1

Venture Round in 2023
FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

Bliq

Series A in 2022
Bliq GmbH, established in 2019 and headquartered in Berlin, Germany, specializes in developing application software for gig workers in the transport industry. Its flagship product, Bliq Ride, enables registered drivers to automate their daily tasks by accepting or rejecting orders from multiple platforms simultaneously. The company's mission is to streamline work organization for rideshare and delivery drivers using traffic data, technology, and collective intelligence. As of now, Bliq employs 25 people.

Merge

Series B in 2022
Merge simplifies secure data access by offering Unified APIs across key software categories like HRIS, accounting, CRM, and file storage. It handles the entire integration lifecycle, from initial build to maintenance, enabling thousands of companies to unblock sales, reduce churn, accelerate product launch, and save engineering resources.

Ledgy

Series B in 2022
Ledgy develops a valuation tracking platform to manage equity capital and employee participation. The platform streamlines vesting plans, phantom programs, and numbered shares, digitizing equity management to provide entrepreneurs and shareholders with clear insights into their capital table, financing rounds, and exit talks. Founded in 2017 in Zurich, Switzerland, Ledgy supports startups and growing companies in planning and communicating equity arrangements for stakeholders.

ZeroFOX

Post in 2022
ZeroFOX is a cybersecurity company that provides external threat intelligence and protection against social media–based threats. It operates a cloud-based platform delivering real-time social threat analytics, protection, and monitoring to safeguard brands, people, and data across the public attack surface. Its solutions address phishing, credential compromise, impersonation, information leakage, brand hijacking, and physical or reputational risks to executives and high-profile individuals, with services including managed monitoring and protection. The company supports industries such as financial services, retail, government, healthcare, technology, education, media, and sports, and offers specialized protections for elections and high-value personnel.

Omio

Series E in 2022
Founded in 2012, Omio operates a multi-modal travel platform that enables users to compare, plan, and book various modes of transportation including trains, buses, flights, and hotels. The platform uses real-time data to suggest optimal routes, estimate travel time, and provide cost comparisons across different travel options.

Bliq

Series A in 2022
Bliq GmbH, established in 2019 and headquartered in Berlin, Germany, specializes in developing application software for gig workers in the transport industry. Its flagship product, Bliq Ride, enables registered drivers to automate their daily tasks by accepting or rejecting orders from multiple platforms simultaneously. The company's mission is to streamline work organization for rideshare and delivery drivers using traffic data, technology, and collective intelligence. As of now, Bliq employs 25 people.

Splice Bio

Series A in 2022
Splice Bio is a biotechnology company based in Barcelona, Spain, that specializes in developing innovative gene therapies using its proprietary intein platform technology. Founded in 2012, the company focuses on addressing the needs of patients suffering from incurable genetic diseases. Splice Bio's technology, originally developed in the Muir Lab at Princeton University, enhances the capabilities of traditional adeno-associated viruses (AAVs) by allowing for larger gene cargo delivery and targeting a broader range of tissues. This advancement aims to overcome existing limitations in gene therapy, making it a promising solution for treating complex genetic disorders. The company was formerly known as Proteodesign, S.L. before rebranding to Splice Bio in September 2020.

Aquabyte

Venture Round in 2022
Founded in 2017, Aquabyte specializes in developing smart camera systems and machine learning models for aquaculture. Its solutions include real-time sea lice counting, biomass monitoring, appetite detection, and feed optimization, aiming to enhance fish farm efficiency, sustainability, and profitability.

AviadoBio

Series A in 2021
AviadoBio focuses on developing transformative gene therapies for devastating neurodegenerative disorders such as frontotemporal dementia and amyotrophic lateral sclerosis. The company's platform combines proprietary technologies with a deep understanding of the brain to deliver effective treatments.

Merge

Series A in 2021
Merge simplifies secure data access by offering Unified APIs across key software categories like HRIS, accounting, CRM, and file storage. It handles the entire integration lifecycle, from initial build to maintenance, enabling thousands of companies to unblock sales, reduce churn, accelerate product launch, and save engineering resources.

Kiswe

Venture Round in 2021
Kiswe specializes in enhancing live event viewing by connecting at-home audiences with in-venue fans through interactive video experiences. Its cloud-based Kiswe Studio transforms professional event production and broadcasting. Serving global broadcasters, sports leagues, and music labels like Big Hit Entertainment (BTS), NBA, Globo, MLS, PGA Tour, and Turner Sports.

Attest

Series B in 2021
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.

Inkitt

Series B in 2021
Inkitt operates an online community for writers and readers, offering a platform where authors can share and refine their work while gaining insights from readers. The company uses data-driven approaches to identify popular stories and publishes them across various media, aiming to create blockbuster franchises similar to Disney's model.

Databricks

Series H in 2021
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.

Merge

Seed Round in 2021
Merge simplifies secure data access by offering Unified APIs across key software categories like HRIS, accounting, CRM, and file storage. It handles the entire integration lifecycle, from initial build to maintenance, enabling thousands of companies to unblock sales, reduce churn, accelerate product launch, and save engineering resources.

ThreatQuotient

Debt Financing in 2021
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

ThreatQuotient

Venture Round in 2021
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

Nuvolo

Series C in 2021
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

WireWheel

Series B in 2021
WireWheel, Inc. is a software company specializing in data privacy management solutions, designed to assist organizations in complying with various data protection regulations such as the EU GDPR and HIPAA. Established in 2016 and headquartered in Arlington, Virginia, WireWheel offers a cloud-based platform that integrates machine learning and data science to streamline privacy program management and subject rights request handling. The platform facilitates the automatic mapping of public cloud assets and aids in managing third-party relationships, enabling organizations to effectively navigate compliance obligations while maximizing the value of their data assets. WireWheel's innovative approach positions its clients to operationalize privacy effectively within their enterprises.

Databricks

Series G in 2021
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.

Splashtop

Series E in 2021
Splashtop delivers remote access and remote support software and services for enterprises, educational and research institutions, government agencies, small businesses, managed service providers, IT departments, and individuals. It enables users to access and control applications, files, and data from mobile devices or other computers through its remote desktop solutions. The product lineup includes On-Demand Support, Personal, Enterprise, and Business remote access offerings. Additional tools include Mirroring360 for wireless screen sharing and recording, Classroom for teachers to share desktops, Whiteboard for turning tablets into interactive boards, and Wired XDisplay to convert iPads or iPhones into high-performance monitors. Founded in 2006 and headquartered in San Jose, California, Splashtop serves customers worldwide with offices in China, Japan, Taiwan, and the Netherlands.

KONUX

Series C in 2021
KONUX GmbH is a German company based in Munich, founded in 2014, that specializes in developing Industrial Internet of Things (IIoT) solutions for railway and industrial applications. The company integrates smart sensor systems with artificial intelligence-driven analytics to provide real-time monitoring of asset and infrastructure conditions, enabling predictive maintenance and enhancing operational efficiency. KONUX's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and customized hardware solutions. By leveraging machine learning and IoT technologies, KONUX aims to transform railway operations, making them more sustainable, reliable, and cost-effective. The company has expanded its footprint across Europe and Asia and has gained recognition as one of the most innovative startups globally, underscoring its commitment to modernizing transportation systems.

DataRobot

Series F in 2020
DataRobot develops an automated machine learning platform that enables users across various industries to build predictive models. Its cloud-based solution, DataRobot Cloud, offers a project-based curriculum for gaining insights from data scientists. The company also provides DataRobot MLOps for deploying and managing machine learning models, along with enterprise features like flexible deployment and governance in its DataRobot Enterprise solution.

Polyneuron Pharmaceuticals

Series A in 2020
Polyneuron Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapeutics for the treatment of autoimmune disorders. Founded in 2014, the company specializes in creating drugs to target specific autoimmune conditions, including PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron's therapeutic approach employs biodegradable glycopolymers that selectively eliminate pathological autoantibodies, preserving the overall integrity of the immune system. This technology, referred to as Antibody-Catch, aims to provide safe and effective treatment options for patients suffering from autoimmune diseases affecting the peripheral nervous system, particularly those involving autoantibodies against carbohydrate epitopes.

Omio

Venture Round in 2020
Founded in 2012, Omio operates a multi-modal travel platform that enables users to compare, plan, and book various modes of transportation including trains, buses, flights, and hotels. The platform uses real-time data to suggest optimal routes, estimate travel time, and provide cost comparisons across different travel options.

Attest

Venture Round in 2020
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.

ZeroFOX

Series D in 2020
ZeroFOX is a cybersecurity company that provides external threat intelligence and protection against social media–based threats. It operates a cloud-based platform delivering real-time social threat analytics, protection, and monitoring to safeguard brands, people, and data across the public attack surface. Its solutions address phishing, credential compromise, impersonation, information leakage, brand hijacking, and physical or reputational risks to executives and high-profile individuals, with services including managed monitoring and protection. The company supports industries such as financial services, retail, government, healthcare, technology, education, media, and sports, and offers specialized protections for elections and high-value personnel.

Inventiva Pharma

Post in 2020
Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

erytech

Post in 2020
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company based in Lyon, France, founded in 2004. The company specializes in the development of red blood cell-based therapeutics aimed at treating cancer and orphan diseases. Its lead product candidate, eryaspase, is currently undergoing Phase III clinical trials for second-line pancreatic cancer and Phase II trials for triple-negative breast cancer. Additionally, ERYTECH is developing erymethionase, a preclinical candidate targeting methionine-dependent cancers, which consists of methionine-gamma-lyase encapsulated in red blood cells. The company collaborates with research institutions such as the Fox Chase Cancer Center and Queen’s University of Canada to enhance the preclinical development of its products for conditions like homocystinuria and arginase-1 deficiency, respectively. Through its innovative approach to encapsulating therapeutic molecules, ERYTECH Pharma aims to improve the efficacy and safety of its treatments.

Flow Commerce

Series B in 2019
Flow Commerce, Inc. is a technology company that specializes in cross-border e-commerce solutions, facilitating international sales for online merchants. Founded in 2015 and headquartered in Hoboken, New Jersey, with an office in Dublin, Ireland, Flow provides a versatile platform that allows e-commerce businesses to easily configure their global supply chain and meet overseas demand. The platform addresses the complexities of international commerce by offering tools for multi-currency pricing, rapid shipping, international payment processing, tax management, and logistics. Flow's solution can be utilized as a comprehensive end-to-end system or as modular components, making it accessible for e-commerce companies of all sizes. By simplifying the buying and selling process across borders, Flow Commerce enhances the overall experience for both merchants and consumers.

Databricks

Series F in 2019
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.

Inventiva Pharma

Post in 2019
Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

DataRobot

Series E in 2019
DataRobot develops an automated machine learning platform that enables users across various industries to build predictive models. Its cloud-based solution, DataRobot Cloud, offers a project-based curriculum for gaining insights from data scientists. The company also provides DataRobot MLOps for deploying and managing machine learning models, along with enterprise features like flexible deployment and governance in its DataRobot Enterprise solution.

Yubico

Venture Round in 2019
Yubico AB is a company specializing in authentication solutions aimed at enhancing digital security for enterprises and online services. Founded in 2007 and headquartered in Stockholm, Sweden, with an additional location in Sunnyvale, California, Yubico is renowned for its YubiKey, a hardware authentication token that provides strong two-factor authentication through a simple USB interface. The YubiKey is compatible with numerous platforms and services, offering various authentication methods such as one-time passcodes and passwordless login, which help prevent unauthorized access and identity theft. Yubico also offers YubiEnterprise Delivery, a cloud-based service for efficient YubiKey distribution, and YubiKey Firmware for secure pre-boot settings. The company's clientele includes individual developers, universities, and government entities, reflecting its broad impact across diverse industries including healthcare, finance, and technology. Yubico continues to innovate, expanding its product offerings to address the evolving challenges of digital security.

Nuvolo

Series B in 2019
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

Aquabyte

Series A in 2019
Founded in 2017, Aquabyte specializes in developing smart camera systems and machine learning models for aquaculture. Its solutions include real-time sea lice counting, biomass monitoring, appetite detection, and feed optimization, aiming to enhance fish farm efficiency, sustainability, and profitability.

Attest

Series A in 2019
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.

Polyneuron Pharmaceuticals

Series A in 2019
Polyneuron Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapeutics for the treatment of autoimmune disorders. Founded in 2014, the company specializes in creating drugs to target specific autoimmune conditions, including PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron's therapeutic approach employs biodegradable glycopolymers that selectively eliminate pathological autoantibodies, preserving the overall integrity of the immune system. This technology, referred to as Antibody-Catch, aims to provide safe and effective treatment options for patients suffering from autoimmune diseases affecting the peripheral nervous system, particularly those involving autoantibodies against carbohydrate epitopes.

Casper

Series D in 2019
Casper Sleep Inc. is a company that designs and sells a variety of sleep products, including mattresses, pillows, sheets, duvets, and bedroom furniture. Founded in 2014 and headquartered in New York, the company aims to provide consumers with high-quality sleep solutions while eliminating inflated prices typically associated with traditional retail models. Casper's products are developed in-house by a team of experienced engineers, ensuring comfort and innovation. The company distributes its offerings through an e-commerce platform, a network of retail stores, and various retail partners across the United States, Canada, and Europe. In addition to its core product line, Casper also provides sleep accessories and technology, catering to the diverse needs of customers seeking better sleep.

Movius

Series D in 2019
Movius provides cloud-based enterprise mobility solutions via a software-as-a-service platform that extends corporate communication capabilities to mobile devices. The company offers secure mobile communications, helps organizations meet compliance requirements, and improves productivity by enabling separate work lines on a single device. Its platform includes a set of pre-packaged applications and APIs to support application development and integration, along with support and training services. Movius serves telecommunications providers, businesses, and end users globally, with headquarters in Atlanta and regional offices in Dubai, Madrid, Bengaluru, and Johannesburg.

Drop

Series B in 2019
Drop is a consumer rewards platform that uses machine learning to match shoppers with over 400 partner brands, enabling them to earn points, discounts, and cashback on purchases. The service encourages repeat shopping by offering instant rewards and personalized offers. Headquartered in Toronto, Drop serves more than 4 million members across North America and the UK, aiming to improve everyday consumer experiences through its personalized commerce platform.

KONUX

Series B in 2019
KONUX GmbH is a German company based in Munich, founded in 2014, that specializes in developing Industrial Internet of Things (IIoT) solutions for railway and industrial applications. The company integrates smart sensor systems with artificial intelligence-driven analytics to provide real-time monitoring of asset and infrastructure conditions, enabling predictive maintenance and enhancing operational efficiency. KONUX's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and customized hardware solutions. By leveraging machine learning and IoT technologies, KONUX aims to transform railway operations, making them more sustainable, reliable, and cost-effective. The company has expanded its footprint across Europe and Asia and has gained recognition as one of the most innovative startups globally, underscoring its commitment to modernizing transportation systems.

Databricks

Series E in 2019
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.

WireWheel

Series A in 2018
WireWheel, Inc. is a software company specializing in data privacy management solutions, designed to assist organizations in complying with various data protection regulations such as the EU GDPR and HIPAA. Established in 2016 and headquartered in Arlington, Virginia, WireWheel offers a cloud-based platform that integrates machine learning and data science to streamline privacy program management and subject rights request handling. The platform facilitates the automatic mapping of public cloud assets and aids in managing third-party relationships, enabling organizations to effectively navigate compliance obligations while maximizing the value of their data assets. WireWheel's innovative approach positions its clients to operationalize privacy effectively within their enterprises.

DataRobot

Series D in 2018
DataRobot develops an automated machine learning platform that enables users across various industries to build predictive models. Its cloud-based solution, DataRobot Cloud, offers a project-based curriculum for gaining insights from data scientists. The company also provides DataRobot MLOps for deploying and managing machine learning models, along with enterprise features like flexible deployment and governance in its DataRobot Enterprise solution.

Forter

Series D in 2018
Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

StreamSets

Series C in 2018
StreamSets, Inc. is a developer of a cloud-based DataOps platform that facilitates modern data integration for enterprises, enabling the continuous flow of big, streaming, and traditional data into data science and analytics applications. Founded in 2014 and headquartered in San Francisco, California, the company offers solutions such as StreamSets Control Hub for designing and monitoring data pipelines, StreamSets Data Collector as an open-source execution engine for managing both streaming and batch data, and StreamSets Transformer for building data transformations across various sources. The platform supports diverse use cases, including integration for data lakes and warehouses, cloud data storage adoption, and the powering of real-time applications. StreamSets serves enterprise clients both in the United States and internationally, with additional offices in locations including Sunnyvale, Austin, London, Barcelona, Bengaluru, and Sydney.

KONUX

Series B in 2018
KONUX GmbH is a German company based in Munich, founded in 2014, that specializes in developing Industrial Internet of Things (IIoT) solutions for railway and industrial applications. The company integrates smart sensor systems with artificial intelligence-driven analytics to provide real-time monitoring of asset and infrastructure conditions, enabling predictive maintenance and enhancing operational efficiency. KONUX's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and customized hardware solutions. By leveraging machine learning and IoT technologies, KONUX aims to transform railway operations, making them more sustainable, reliable, and cost-effective. The company has expanded its footprint across Europe and Asia and has gained recognition as one of the most innovative startups globally, underscoring its commitment to modernizing transportation systems.

Vina

Seed Round in 2018
Vina, Inc. is a company that focuses on creating networking and communication platforms aimed at empowering women. Founded in 2016 and based in San Francisco, California, Vina operates the Hey! VINA app, which serves as a social networking tool for women to meet new friends, as well as LadyBrag.com, a platform encouraging women to recognize and share their achievements. Through these products, Vina facilitates connections among women primarily in the United States, the United Kingdom, Canada, and Australia, enabling them to celebrate their successes and support one another in a collaborative environment.

Drop

Series A in 2018
Drop is a consumer rewards platform that uses machine learning to match shoppers with over 400 partner brands, enabling them to earn points, discounts, and cashback on purchases. The service encourages repeat shopping by offering instant rewards and personalized offers. Headquartered in Toronto, Drop serves more than 4 million members across North America and the UK, aiming to improve everyday consumer experiences through its personalized commerce platform.

Aquabyte

Seed Round in 2018
Founded in 2017, Aquabyte specializes in developing smart camera systems and machine learning models for aquaculture. Its solutions include real-time sea lice counting, biomass monitoring, appetite detection, and feed optimization, aiming to enhance fish farm efficiency, sustainability, and profitability.

FIRE1

Series C in 2018
FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

WireWheel

Seed Round in 2017
WireWheel, Inc. is a software company specializing in data privacy management solutions, designed to assist organizations in complying with various data protection regulations such as the EU GDPR and HIPAA. Established in 2016 and headquartered in Arlington, Virginia, WireWheel offers a cloud-based platform that integrates machine learning and data science to streamline privacy program management and subject rights request handling. The platform facilitates the automatic mapping of public cloud assets and aids in managing third-party relationships, enabling organizations to effectively navigate compliance obligations while maximizing the value of their data assets. WireWheel's innovative approach positions its clients to operationalize privacy effectively within their enterprises.

ThreatQuotient

Series C in 2017
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

ObsEva

Post in 2017
ObsEva SA is a clinical-stage biopharmaceutical company based in Geneva, Switzerland, dedicated to developing innovative therapeutics for women's reproductive health and pregnancy. Founded in 2012 by Ernest Loumaye and André Chollet, the company focuses on addressing serious conditions affecting women. Its key products in development include Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist aimed at treating pain from endometriosis and heavy menstrual bleeding associated with uterine fibroids. ObsEva is also working on OBE022, a once-daily oral prostaglandin F2α receptor antagonist designed for managing preterm labor between 24 and 34 weeks of gestation, and Nolasiban, an oral oxytocin receptor antagonist intended to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company operates primarily within the Swiss market while targeting global solutions for women's reproductive health needs.

Databricks

Series D in 2017
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.

DataRobot

Series C in 2017
DataRobot develops an automated machine learning platform that enables users across various industries to build predictive models. Its cloud-based solution, DataRobot Cloud, offers a project-based curriculum for gaining insights from data scientists. The company also provides DataRobot MLOps for deploying and managing machine learning models, along with enterprise features like flexible deployment and governance in its DataRobot Enterprise solution.

Segment

Series C in 2017
Segment.io, Inc. is a company that specializes in customer data infrastructure, enabling businesses to collect, unify, and connect their customer data across various platforms. Founded in 2011 and headquartered in San Francisco, California, Segment offers a single API that allows organizations to track customer information across multiple devices and channels. This data can be seamlessly sent to a variety of third-party tools, internal systems, or SQL databases. Additionally, Segment provides a product known as Data Lakes, which assists companies in leveraging their customer data to enhance user experiences. The company also maintains an office in Dublin, Ireland, and operates as a subsidiary of Twilio Inc. as of November 2020.

Nightstar Therapeutics

Series C in 2017
Nightstar Therapeutics is a clinical-stage gene therapy company based in London, United Kingdom, specializing in the development of innovative one-time treatments for rare inherited retinal diseases. The company is advancing several product candidates, including its lead candidate NSR-REP1, which is in phase 3 clinical development for choroideremia. Additionally, Nightstar is working on NSR-RPGR, currently in phase 2/3 trials for X-linked retinitis pigmentosa, as well as NSR-BEST1. The company is also developing NSR-ABCA4, which is in preclinical development for Stargardt disease. Founded in 2017, Nightstar Therapeutics aims to address significant unmet medical needs in the field of retinal disorders.

Topia

Series C in 2017
Topia develops and provides mobility management solutions for businesses worldwide. Its platform automates global talent mobility processes, including relocation administration, tax and immigration management, expatriate payroll, and scenario-based planning. Topia serves prominent clients such as Schneider Electric, Dell, Veolia, Equinor, and AXA.

Nuvolo

Series A in 2017
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

Movius

Series C in 2017
Movius provides cloud-based enterprise mobility solutions via a software-as-a-service platform that extends corporate communication capabilities to mobile devices. The company offers secure mobile communications, helps organizations meet compliance requirements, and improves productivity by enabling separate work lines on a single device. Its platform includes a set of pre-packaged applications and APIs to support application development and integration, along with support and training services. Movius serves telecommunications providers, businesses, and end users globally, with headquarters in Atlanta and regional offices in Dubai, Madrid, Bengaluru, and Johannesburg.

Casper

Series C in 2017
Casper Sleep Inc. is a company that designs and sells a variety of sleep products, including mattresses, pillows, sheets, duvets, and bedroom furniture. Founded in 2014 and headquartered in New York, the company aims to provide consumers with high-quality sleep solutions while eliminating inflated prices typically associated with traditional retail models. Casper's products are developed in-house by a team of experienced engineers, ensuring comfort and innovation. The company distributes its offerings through an e-commerce platform, a network of retail stores, and various retail partners across the United States, Canada, and Europe. In addition to its core product line, Casper also provides sleep accessories and technology, catering to the diverse needs of customers seeking better sleep.

Conviva

Venture Round in 2017
Conviva, Inc. is a technology company that specializes in optimizing the over-the-top (OTT) video experience for broadcasters, operators, and content owners. Founded in 2006 and headquartered in Foster City, California, with additional offices in major cities worldwide, Conviva offers an intelligent control platform that enhances video quality and viewer engagement across various devices. Its solutions include Conviva Insights, which aggregates quality metrics for better business insights, and Conviva Precision, which provides real-time Global Video Intelligence for a broadcast-like experience. The platform processes nearly 3 trillion streaming data events daily, supporting over 500 million unique viewers and 200 billion streams annually. Conviva serves a wide range of clients, including major brands in entertainment and sports, enabling them to understand viewing trends, retain subscribers, and deliver personalized experiences. The company has also established strategic partnerships to further enhance its offerings in the competitive streaming landscape.

Yubico

Venture Round in 2017
Yubico AB is a company specializing in authentication solutions aimed at enhancing digital security for enterprises and online services. Founded in 2007 and headquartered in Stockholm, Sweden, with an additional location in Sunnyvale, California, Yubico is renowned for its YubiKey, a hardware authentication token that provides strong two-factor authentication through a simple USB interface. The YubiKey is compatible with numerous platforms and services, offering various authentication methods such as one-time passcodes and passwordless login, which help prevent unauthorized access and identity theft. Yubico also offers YubiEnterprise Delivery, a cloud-based service for efficient YubiKey distribution, and YubiKey Firmware for secure pre-boot settings. The company's clientele includes individual developers, universities, and government entities, reflecting its broad impact across diverse industries including healthcare, finance, and technology. Yubico continues to innovate, expanding its product offerings to address the evolving challenges of digital security.

StreamSets

Series B in 2017
StreamSets, Inc. is a developer of a cloud-based DataOps platform that facilitates modern data integration for enterprises, enabling the continuous flow of big, streaming, and traditional data into data science and analytics applications. Founded in 2014 and headquartered in San Francisco, California, the company offers solutions such as StreamSets Control Hub for designing and monitoring data pipelines, StreamSets Data Collector as an open-source execution engine for managing both streaming and batch data, and StreamSets Transformer for building data transformations across various sources. The platform supports diverse use cases, including integration for data lakes and warehouses, cloud data storage adoption, and the powering of real-time applications. StreamSets serves enterprise clients both in the United States and internationally, with additional offices in locations including Sunnyvale, Austin, London, Barcelona, Bengaluru, and Sydney.

Frontier Car Group

Series A in 2017
Frontier Car Group is a Berlin-based startup focused on developing and operating used automotive marketplaces in emerging markets, including Nigeria, Mexico, Argentina, Colombia, Chile, Pakistan, and Indonesia. The company aims to simplify the process of buying and selling used cars through its online platform, which features a digital quote engine that provides instant pricing for vehicles. This technology not only enhances the efficiency of transactions but also facilitates quick vehicle inspections at designated locations. By leveraging innovative business models and infrastructure, Frontier Car Group is able to create value for all stakeholders involved in the used car market. Additionally, the company is engaged in joint ventures with OLX in India and Poland, further expanding its reach and impact in the automotive sector.

KONUX

Series A in 2017
KONUX GmbH is a German company based in Munich, founded in 2014, that specializes in developing Industrial Internet of Things (IIoT) solutions for railway and industrial applications. The company integrates smart sensor systems with artificial intelligence-driven analytics to provide real-time monitoring of asset and infrastructure conditions, enabling predictive maintenance and enhancing operational efficiency. KONUX's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and customized hardware solutions. By leveraging machine learning and IoT technologies, KONUX aims to transform railway operations, making them more sustainable, reliable, and cost-effective. The company has expanded its footprint across Europe and Asia and has gained recognition as one of the most innovative startups globally, underscoring its commitment to modernizing transportation systems.

Addex Therapeutics

Post in 2017
Addex Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing oral small-molecule drugs that act as allosteric modulators of central nervous system targets, especially G-protein coupled receptors. Based in Geneva, Switzerland, the company aims to address CNS disorders with a platform that may offer advantages over conventional orthosteric therapies. Its lead programs include Dipraglurant for Parkinson's disease levodopa-induced dyskinesia and dystonia, ADX71149 for epilepsy and other CNS conditions, and a GABAB positive allosteric modulator for addiction. It collaborates with Janssen Pharmaceuticals to develop mGluR2 PAM compounds. Founded in 2002, Addex operates in Switzerland and Europe, pursuing discovery, development, and potential commercialization of small-molecule therapeutics for CNS disorders.

ClearMotion

Series C in 2017
ClearMotion, Inc. is an automotive technology company that specializes in developing advanced suspension systems to enhance vehicle comfort and handling. Founded out of MIT in 2008 and based in Billerica, Massachusetts, with operations in Nuneaton, United Kingdom, ClearMotion integrates hardware and software to create a proactive ride system that anticipates and counteracts shocks and vibrations from uneven road surfaces. This innovative technology not only improves ride quality but also enhances the overall user experience in vehicles. By mapping road surfaces in real-time, ClearMotion's system can mitigate the effects of road roughness almost instantaneously, ensuring a smoother ride for both drivers and passengers.

Peanut App

Seed Round in 2017
Peanut App Limited is a London-based company that has developed a social networking application designed to connect mothers with similar interests and children of comparable ages. Launched in 2016, the app provides a platform for women to create group chats and organize face-to-face meetings, fostering a sense of community and support among users. Peanut aims to offer a safe space for women to build friendships, share experiences, and learn from one another, making it a unique resource for mothers navigating similar life stages. The application is available for free on both iOS and Android devices.

Cartiva

Series E in 2017
Cartiva, Inc. is a medical device company focused on developing innovative solutions for orthopedic surgeons and patients suffering from osteoarthritis and cartilage damage. Founded in 2011 and headquartered in Alpharetta, Georgia, Cartiva markets the Cartiva Synthetic Cartilage Implant, which is designed to mimic natural cartilage and alleviate pain by restoring the joint structure in affected areas, including the first metatarsophalangeal joint, ankle, and knee. Additionally, Cartiva offers the ProxiFuse Hammertoe Correction System for the fixation of osteotomies and reconstruction of lesser toes. The company sells its products through various distributors in regions such as Brazil, Canada, and the United Kingdom. With a management team and board composed of experts in orthopedics, Cartiva aims to enhance patient outcomes through effective treatments for cartilage injuries and related discomfort. As of October 2018, Cartiva operates as a subsidiary of a larger medical group.

Databricks

Series C in 2016
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.

Vina

Seed Round in 2016
Vina, Inc. is a company that focuses on creating networking and communication platforms aimed at empowering women. Founded in 2016 and based in San Francisco, California, Vina operates the Hey! VINA app, which serves as a social networking tool for women to meet new friends, as well as LadyBrag.com, a platform encouraging women to recognize and share their achievements. Through these products, Vina facilitates connections among women primarily in the United States, the United Kingdom, Canada, and Australia, enabling them to celebrate their successes and support one another in a collaborative environment.

ThreatQuotient

Series B in 2016
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

Forter

Series C in 2016
Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

FIRE1

Series B in 2016
FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

KONUX

Series A in 2016
KONUX GmbH is a German company based in Munich, founded in 2014, that specializes in developing Industrial Internet of Things (IIoT) solutions for railway and industrial applications. The company integrates smart sensor systems with artificial intelligence-driven analytics to provide real-time monitoring of asset and infrastructure conditions, enabling predictive maintenance and enhancing operational efficiency. KONUX's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and customized hardware solutions. By leveraging machine learning and IoT technologies, KONUX aims to transform railway operations, making them more sustainable, reliable, and cost-effective. The company has expanded its footprint across Europe and Asia and has gained recognition as one of the most innovative startups globally, underscoring its commitment to modernizing transportation systems.

DataRobot

Series B in 2016
DataRobot develops an automated machine learning platform that enables users across various industries to build predictive models. Its cloud-based solution, DataRobot Cloud, offers a project-based curriculum for gaining insights from data scientists. The company also provides DataRobot MLOps for deploying and managing machine learning models, along with enterprise features like flexible deployment and governance in its DataRobot Enterprise solution.

Curalate

Series C in 2016
Curalate, Inc. is a technology company that operates an online platform focused on enhancing the connection between visual content and e-commerce. Founded in 2011 and based in Philadelphia, with additional offices in New York, Seattle, and London, the company enables brands to convert images and videos into interactive digital storefronts across various online channels, including social media and advertisements. Curalate's platform offers tools for brands to automate content posting, track social media engagement, and gain insights into campaign performance, competitors, and influencers. By leveraging image recognition algorithms, Curalate facilitates a seamless transition from consumer discovery of products to actual purchases, working with prominent brands such as Gap, Neiman Marcus, and Sephora to drive revenue through visual-driven commerce. Curalate, previously known as Storably, became a subsidiary of Bazaarvoice in July 2020.

CupoNation

Series B in 2015
CupoNation is a prominent online platform specializing in discount codes and offers, operating in over 24 countries. Founded by Corrado Rota, the company aims to provide users with easy access to savings across a wide array of categories, including fashion, beauty, electronics, and travel. Unlike traditional coupon sites, CupoNation allows users to copy discount codes directly from its website and apply them at partner e-commerce sites without requiring registration. This user-friendly approach has positioned CupoNation as a go-to resource for online shoppers seeking deals from more than 18,000 brands, including notable names like Amazon and Just Eat. The company's strategy involves entering markets with limited competition, starting with India and expanding to countries such as Brazil, Spain, Italy, and the United States. Through this approach, CupoNation continues to grow its international presence while helping customers save money on everyday purchases.

ZeroFOX

Series B in 2015
ZeroFOX is a cybersecurity company that provides external threat intelligence and protection against social media–based threats. It operates a cloud-based platform delivering real-time social threat analytics, protection, and monitoring to safeguard brands, people, and data across the public attack surface. Its solutions address phishing, credential compromise, impersonation, information leakage, brand hijacking, and physical or reputational risks to executives and high-profile individuals, with services including managed monitoring and protection. The company supports industries such as financial services, retail, government, healthcare, technology, education, media, and sports, and offers specialized protections for elections and high-value personnel.

ThreatQuotient

Series A in 2015
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

ObsEva

Series B in 2015
ObsEva SA is a clinical-stage biopharmaceutical company based in Geneva, Switzerland, dedicated to developing innovative therapeutics for women's reproductive health and pregnancy. Founded in 2012 by Ernest Loumaye and André Chollet, the company focuses on addressing serious conditions affecting women. Its key products in development include Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist aimed at treating pain from endometriosis and heavy menstrual bleeding associated with uterine fibroids. ObsEva is also working on OBE022, a once-daily oral prostaglandin F2α receptor antagonist designed for managing preterm labor between 24 and 34 weeks of gestation, and Nolasiban, an oral oxytocin receptor antagonist intended to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company operates primarily within the Swiss market while targeting global solutions for women's reproductive health needs.

Nuvolo

Seed Round in 2015
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

Nightstar Therapeutics

Series B in 2015
Nightstar Therapeutics is a clinical-stage gene therapy company based in London, United Kingdom, specializing in the development of innovative one-time treatments for rare inherited retinal diseases. The company is advancing several product candidates, including its lead candidate NSR-REP1, which is in phase 3 clinical development for choroideremia. Additionally, Nightstar is working on NSR-RPGR, currently in phase 2/3 trials for X-linked retinitis pigmentosa, as well as NSR-BEST1. The company is also developing NSR-ABCA4, which is in preclinical development for Stargardt disease. Founded in 2017, Nightstar Therapeutics aims to address significant unmet medical needs in the field of retinal disorders.

Therachon

Series A in 2015
Therachon is a biotechnology company specializing in the development of treatments for rare genetic diseases that lack available therapies. Primarily based in Basel, Switzerland, with research labs in Nice, France, the company is advancing its lead candidate, TA-46, a novel protein therapy aimed at treating achondroplasia, the most prevalent form of short-limbed dwarfism. In addition to its focus on achondroplasia, Therachon is also committed to developing therapeutics targeting rare gastrointestinal and musculoskeletal disorders, with the goal of enabling medical professionals to effectively manage conditions such as short bowel syndrome.

Acquia

Series G in 2015
Acquia provides a cloud-based platform enabling businesses worldwide to build, deliver, and optimize digital experiences. With clients such as BBC, Nasdaq, Stanford University, and the Australian Government, Acquia accelerates time-to-market and enhances customer engagement through cross-channel, contextually relevant digital experiences.

StreamSets

Series A in 2015
StreamSets, Inc. is a developer of a cloud-based DataOps platform that facilitates modern data integration for enterprises, enabling the continuous flow of big, streaming, and traditional data into data science and analytics applications. Founded in 2014 and headquartered in San Francisco, California, the company offers solutions such as StreamSets Control Hub for designing and monitoring data pipelines, StreamSets Data Collector as an open-source execution engine for managing both streaming and batch data, and StreamSets Transformer for building data transformations across various sources. The platform supports diverse use cases, including integration for data lakes and warehouses, cloud data storage adoption, and the powering of real-time applications. StreamSets serves enterprise clients both in the United States and internationally, with additional offices in locations including Sunnyvale, Austin, London, Barcelona, Bengaluru, and Sydney.

Akari Therapeutics

Post in 2015
Akari Therapeutics is a biopharmaceutical company focused on developing treatments for rare autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan (formerly Coversin), is a dual inhibitor of complement component 5 (C5) and leukotriene B4 (LTB4), currently in clinical trials for bullous pemphigoid, thrombotic microangiopathy, and other indications.

Topia

Series B in 2015
Topia develops and provides mobility management solutions for businesses worldwide. Its platform automates global talent mobility processes, including relocation administration, tax and immigration management, expatriate payroll, and scenario-based planning. Topia serves prominent clients such as Schneider Electric, Dell, Veolia, Equinor, and AXA.

Transifex

Seed Round in 2015
Transifex is a cloud-based localization automation platform that enables organizations to launch digital content in multiple languages. The SaaS platform supports continuous localization through an API and a Git-like command-line client, ensuring new content is translated and delivered with each release. It provides content hosting, team collaboration, and analytics, and supports localization for software, web and mobile apps, websites, games, subtitles, and help centers. Founded in 2009 and headquartered in Menlo Park, California, with operations in Greece, Transifex serves customers globally from startups to large enterprises and localizes content into more than 100 languages.

Casper

Series B in 2015
Casper Sleep Inc. is a company that designs and sells a variety of sleep products, including mattresses, pillows, sheets, duvets, and bedroom furniture. Founded in 2014 and headquartered in New York, the company aims to provide consumers with high-quality sleep solutions while eliminating inflated prices typically associated with traditional retail models. Casper's products are developed in-house by a team of experienced engineers, ensuring comfort and innovation. The company distributes its offerings through an e-commerce platform, a network of retail stores, and various retail partners across the United States, Canada, and Europe. In addition to its core product line, Casper also provides sleep accessories and technology, catering to the diverse needs of customers seeking better sleep.

GumGum

Series C in 2015
GumGum, Inc. is a technology company based in Santa Monica, California, that specializes in artificial intelligence, particularly in computer vision and natural language processing. Founded in 2006, the company focuses on unlocking the value of visual content generated across various platforms, including the web and broadcast television. GumGum provides a range of services, such as in-image advertising, influencer marketing, targeted media buying, and site monetization. Its flagship products include GumGum Visual Intelligence, a platform for real-time visual listening that assists brands in identifying and activating online imagery, and AdBuilder, which allows brands to create and manage in-image and in-screen advertisements. By using advanced machine learning and deep learning technologies, GumGum enhances contextual advertising and aids marketers in maximizing the media value of their investments. The company maintains a presence with additional offices in major cities across the United States, as well as locations in London and Sydney.

Cartiva

Series D in 2015
Cartiva, Inc. is a medical device company focused on developing innovative solutions for orthopedic surgeons and patients suffering from osteoarthritis and cartilage damage. Founded in 2011 and headquartered in Alpharetta, Georgia, Cartiva markets the Cartiva Synthetic Cartilage Implant, which is designed to mimic natural cartilage and alleviate pain by restoring the joint structure in affected areas, including the first metatarsophalangeal joint, ankle, and knee. Additionally, Cartiva offers the ProxiFuse Hammertoe Correction System for the fixation of osteotomies and reconstruction of lesser toes. The company sells its products through various distributors in regions such as Brazil, Canada, and the United Kingdom. With a management team and board composed of experts in orthopedics, Cartiva aims to enhance patient outcomes through effective treatments for cartilage injuries and related discomfort. As of October 2018, Cartiva operates as a subsidiary of a larger medical group.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.